ArticleClinical therapeutics2021

Cost-Effectiveness of Baricitinib Compared With Standard of Care: A Modeling Study in Hospitalized Patients With COVID-19 in the United States.

Robert Ohsfeldt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.